Editor-in-Chief
Designation: Professor
Department: Medicine
Email: michel.bourin@univ-nantes.fr
University: University of Nantes
Country: France
Michel Bourin has held the position of Professor of Pharmacology at the University of Nantes since 1985. After completing his pharmacist and medical training at Tours University he was awarded degrees in neuropsychopharmacology, clinical pharmacology and general pharmacology in Paris and completed his psychiatric training in Nantes.
Since 1988, Professor Bourin has been Head of Research: Neurobiology of Anxiety and Depression. He has also served as an Adjunct Professor in the Department of Psychiatry at the University of Edmonton (Alberta) since 1995 and visiting Professor at University of Craiova (Romania). He is Doctor Honoris Causa of the University of Tartu (Estonia) and University of Craiova (Romania). He is now Psychiatrist in a centre for mental handicapped adults in Montredon (near Narbonne). He has published more than 300 original papers in the field of psychopharmacology and more than 250 educational/review papers both in French and English.
Bipolar disorder and animal models of anxiety and depression
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.